Published in Clin Trials on June 05, 2014
Systolic Blood Pressure Intervention Trial (SPRINT) | NCT01206062
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. JAMA (2016) 5.67
Generalizability of SPRINT Results to the U.S. Adult Population. J Am Coll Cardiol (2015) 2.14
Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial. J Am Soc Hypertens (2015) 2.11
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. Kidney Int (2014) 1.71
Primary prevention: do the very elderly require a different approach? Trends Cardiovasc Med (2014) 1.43
Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial. J Gerontol A Biol Sci Med Sci (2016) 0.97
SPRINT Trial Results: Latest News in Hypertension Management. Hypertension (2015) 0.88
Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension (2016) 0.87
Hypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the Future. Am J Hypertens (2015) 0.86
Blood Pressure in Older Adults: the Importance of Frailty. Curr Hypertens Rep (2015) 0.85
The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg. Blood Press (2016) 0.84
Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension (2016) 0.84
Clinician's guide to the updated ABCs of cardiovascular disease prevention. J Am Heart Assoc (2014) 0.82
Hypertension-attributed nephropathy: what's in a name? Nat Rev Nephrol (2015) 0.82
US Hypertension Management Guidelines: A Review of the Recent Past and Recommendations for the Future. J Am Heart Assoc (2015) 0.82
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume. Kidney Int (2016) 0.81
A call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive decline. Alzheimers Res Ther (2016) 0.81
Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT. J Am Soc Nephrol (2015) 0.79
Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults. Neurology (2016) 0.78
SPS3 Evidence Supports Intensive Blood Pressure Control. Circulation (2016) 0.78
Effects of Intensive BP Control in CKD. J Am Soc Nephrol (2017) 0.78
Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action. Front Aging Neurosci (2016) 0.77
Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions. Am J Nephrol (2016) 0.77
Current and Future Treatment of Hypertension in the SPRINT Era. Methodist Debakey Cardiovasc J (2016) 0.77
Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients with Hypertension: The Systolic Blood Pressure Intervention (SPRINT) Trial. Circulation (2017) 0.77
Does Age Matter? Association Between Usual Source of Care and Hypertension Control in the US Population: Data From NHANES 2007-2012. Am J Hypertens (2016) 0.76
Center for stroke disparities solutions community- based care transition interventions: study protocol of a randomized controlled trial. Trials (2015) 0.75
Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial. Circ Heart Fail (2017) 0.75
Hypertension in 2016: Blood pressure goals, variability and SGLT2 blockade in CKD. Nat Rev Nephrol (2016) 0.75
Baseline blood pressure control in Hispanics: characteristics of Hispanics in the Systolic Blood Pressure Intervention Trial. J Clin Hypertens (Greenwich) (2016) 0.75
The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study. J Am Soc Hypertens (2016) 0.75
BP Targets in Older Adults with CKD: Additional Evidence, but Uncertainty Continues. Clin J Am Soc Nephrol (2015) 0.75
Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial. Hypertension (2016) 0.75
Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry. BMC Endocr Disord (2015) 0.75
Recruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention Trial. Clin Trials (2016) 0.75
Blood Pressure, Sexual Activity, and Dysfunction in Women With Hypertension: Baseline Findings From the Systolic Blood Pressure Intervention Trial (SPRINT). J Sex Med (2016) 0.75
SPRINT and Implications for Target Organ Protection in African Americans. Ethn Dis (2016) 0.75
Hypertension treatment and falls: should we be concerned? J Gen Intern Med (2014) 0.75
Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT). J Hypertens (2016) 0.75
Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. J Am Soc Hypertens (2016) 0.75
Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care (2017) 0.75
APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter. Am J Kidney Dis (2017) 0.75
Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis (2017) 0.75
The 2017 Focused Update of the Guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the Management of Hypertension. Acta Cardiol Sin (2017) 0.75
APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial. KI Rep (2017) 0.75
Changing concepts in hypertension management. J Hum Hypertens (2017) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc (2005) 27.90
General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42
Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12
Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72
Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49
Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04
EQ-5D: a measure of health status from the EuroQol Group. Ann Med (2001) 18.69
The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther (2000) 13.16
The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med (1994) 11.65
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
Measurement of functional activities in older adults in the community. J Gerontol (1982) 10.07
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet (1991) 9.57
Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet (2005) 9.00
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res (1999) 7.14
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet (1998) 6.20
Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA (1997) 5.91
The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther (2005) 5.42
Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet (2013) 5.20
Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke (2001) 4.07
Development and initial validation of the Falls Efficacy Scale-International (FES-I). Age Ageing (2005) 4.01
Hypertension and the risk of mild cognitive impairment. Arch Neurol (2007) 3.62
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol (2008) 3.28
Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension (2001) 3.16
Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension (2006) 3.02
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med (2003) 3.02
Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med (2005) 2.90
A validation study of the Dementia Questionnaire. Arch Neurol (1994) 2.89
Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail (2012) 2.88
A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke (2007) 2.63
Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med (2004) 2.52
The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med (1999) 2.40
Guidelines on preventing cardiovascular disease in clinical practice. BMJ (2000) 2.15
Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep (2004) 2.00
Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators. Neurology (1993) 1.63
Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12). Qual Life Res (2008) 1.60
Update on hypertension and Alzheimer's disease. Neurol Res (2006) 1.55
Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE). Am J Hypertens (2005) 1.47
Successful blood pressure control in the African American Study of Kidney Disease and Hypertension. Arch Intern Med (2002) 1.43
Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives. J Hypertens (1987) 1.31
Validation of a cognitive assessment battery administered over the telephone. J Am Geriatr Soc (2012) 1.26
Hypertension, hypertension-clustering factors and Alzheimer's disease. Neurol Res (2003) 1.14
The science of web-based clinical trial management. Clin Trials (2005) 0.89
Antihypertensive treatment and the J-curve. Cardiovasc Drugs Ther (2000) 0.84
Cost effectiveness of intensive treatment of hypertension. Based on presentations by Donald S. Shepard, PhD; and Dominic Hodgkin, PhD. Am J Manag Care (1998) 0.79
A new twist in the J-shape curve? J Am Geriatr Soc (1999) 0.79
Cardiovascular disease in the United States: an epidemiologic overview. Cardiovasc Clin (1991) 0.79
Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial. J Am Soc Hypertens (2015) 2.11
Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial. J Gerontol A Biol Sci Med Sci (2016) 0.97
SPRINT Trial Results: Latest News in Hypertension Management. Hypertension (2015) 0.88
Sleep duration, cognitive decline, and dementia risk in older women. Alzheimers Dement (2015) 0.85
Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension (2016) 0.84
Urinary Tract Stones and Osteoporosis: Findings From the Women's Health Initiative. J Bone Miner Res (2015) 0.81
Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults. Neurology (2016) 0.78
Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Am Soc Hypertens (2016) 0.77
Measuring vascular reactivity with resting-state blood oxygenation level-dependent (BOLD) signal fluctuations: A potential alternative to the breath-holding challenge? J Cereb Blood Flow Metab (2016) 0.76
Blood Pressure, Sexual Activity, and Dysfunction in Women With Hypertension: Baseline Findings From the Systolic Blood Pressure Intervention Trial (SPRINT). J Sex Med (2016) 0.75
Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial. Hypertension (2016) 0.75
The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study. J Am Soc Hypertens (2016) 0.75
Dietary Inflammatory Index, Bone Mineral Density and Risk of Fracture in Postmenopausal Women: Results from the Women's Health Initiative. J Bone Miner Res (2016) 0.75
Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. J Am Soc Hypertens (2016) 0.75
Variability and rapid increase in body mass index during childhood are associated with adult obesity. Int J Epidemiol (2015) 0.75
Recruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention Trial. Clin Trials (2016) 0.75
Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis (2017) 0.75
Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women. Cancer Causes Control (2017) 0.75
The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial). J Clin Hypertens (Greenwich) (2017) 0.75
Comparison of an alternative schedule of extended care contacts to a self-directed control: a randomized trial of weight loss maintenance. Int J Behav Nutr Phys Act (2017) 0.75
Association of Albuminuria and Estimated Glomerular Filtration Rate with Functional Performance Measures in Older Adults with Chronic Kidney Disease. Am J Nephrol (2017) 0.75
Long-term impact of intensive lifestyle intervention on cognitive function assessed with the National Institutes of Health Toolbox: The Look AHEAD study. Alzheimers Dement (Amst) (2017) 0.75
Association of Tea-drinking Habits with the Risk of Non-Hodgkin Lymphoma - A Prospective Cohort Study among Postmenopausal Women. Br J Nutr (2022) 0.75